IP Verse

Georg Kalhammer/stephan Teipel opposition analysis

COMPANY ANALYSIS

Patent Number:

Title:

Pharmaceutical Oral Dosage Forms Comprising Dabigatran Etexilate And Its Pharmaceutically Acceptable Salts

Applicant:

Opposition Date:

Jan 19, 2018

Patent Number:

Title:

Prodrugs Of Phosphonate Nucleotide Analogues And Methods For Selecting And Making Same

Applicant:

Opposition Date:

Jan 19, 2018

Patent Number:

Title:

Dihydrate Of Benzothiophene Compound Or Of A Salt Thereof, And Process For Producing The Same

Applicant:

Opposition Date:

Sep 28, 2017

Patent Number	Title	Applicant	Opposition Date
EP2588090	Pharmaceutical Oral Dosage Forms Comprising Dabigatran Etexilate And Its Pharmaceutically Acceptable Salts	KRKA TOVARNA ZDRAVIL, D.D., NOVO MESTO	Jan 19, 2018
EP2682397	Prodrugs Of Phosphonate Nucleotide Analogues And Methods For Selecting And Making Same	GILEAD SCIENCES, INC.	Jan 19, 2018
EP2841431	Dihydrate Of Benzothiophene Compound Or Of A Salt Thereof, And Process For Producing The Same	OTSUKA PHARMACEUTICAL CO., LIMITED	Sep 28, 2017

GILEAD SCIENCES, INC.

KRKA TOVARNA ZDRAVIL, D.D., NOVO MESTO

KRKA, TOVARNA ZDRAVIL, D.D., NOVO MESTO

Feel free to send us a message here and we will get back to you